The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

5 articles for AM Klutz


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Probing distal regions of the A2B adenosine receptor by quantitative structure-activity relationship modeling of known and novel agonists.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.EBI
Ewha Womans University
Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
"Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.EBI
National Institute of Diabetes and Digestive and Kidney Diseases